Invention Grant
- Patent Title: Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors
-
Application No.: US18061610Application Date: 2022-12-05
-
Publication No.: US11976049B2Publication Date: 2024-05-07
- Inventor: Adam Galan , Wendy Luo , Ritu Lal
- Applicant: GEN1E LIFESCIENCES INC.
- Applicant Address: US CA Palo Alto
- Assignee: GEN1E LIFESCIENCES INC.
- Current Assignee: GEN1E LIFESCIENCES INC.
- Current Assignee Address: US CA Palo Alto
- Main IPC: C07D265/32
- IPC: C07D265/32 ; A61P35/00 ; C07D295/135
Abstract:
Substituted naphthyl p38α mitogen-activated protein kinase inhibitors, pharmaceutical compositions thereof, and the use of the substituted naphthyl p38α mitogen-activated protein kinase inhibitors and pharmaceutical compositions thereof for treating diseases are disclosed.
Public/Granted literature
- US20230227417A1 SUBSTITUTED NAPHTHYL P38ALPHA MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS Public/Granted day:2023-07-20
Information query
